Future challenges in head and neck cancer: From the bench to the bedside?

January 10th, 2013|

Posted by AROME webmaster on January 10, 2013
Future challenges in head and neck cancer: From the bench to the bedside? Calabrese L, Ostuni A, Ansarin M, Giugliano G, Maffini F, Alterio D, Rocca MC, Petralia G, Bruschini…

Larynx preservation: What is the standard treatment?

January 10th, 2013|

Posted by AROME webmaster on January 10, 2013
Larynx preservation: What is the standard treatment? Horn S, Ozsahin M, Lefèbvre JL, Horiot JC, Lartigau E; on behalf of AROME. Crit Rev Oncol Hematol. 2010 Dec 23. PMID:21185198

Biologic tools to personalize treatment in genitourinary cancers

January 10th, 2013|

Biologic tools to personalize treatment in genitourinary cancers. Bracarda S, Sisani M, Del Buono S, Ishiwa O, Montagnani F; on behalf of AROME. Crit Rev Oncol Hematol. 2011 Jan 12. PMID:21232974]
http://download.journals.elsevierhealth.com/pdfs/journals/1040-8428/PIIS1040842810002222.pdf
by AROME webmaster, 10 Jan 2013

Controversies in the management of localized prostate cancer: Radical prostatectomy still

January 10th, 2013|

Controversies in the management of localized prostate cancer: Radical prostatectomy still the standard of care. Budäus L, Huland H, Graefen M; on behalf of AROME, Association of Radiotherapy and Oncology of the Mediterranean arEa. Crit Rev Oncol Hematol. 2011 May 23. PMID:21612943
by AROME webmaster, 10 Jan 2013

Secondary malignancies in survivors of breast cancer: How to overcome the risk.

January 10th, 2013|

Secondary malignancies in survivors of breast cancer: How to overcome the risk. Shilkrut M, Belkacemi Y, Kuten A; on behalf of AROME. Crit Rev Oncol Hematol. 2011 Nov 6. PMID:22056996
by AROME webmaster, 10 Jan 2013

First data on direct costs of lung cancer management in Morocco.

January 10th, 2013|

First data on direct costs of lung cancer management in Morocco. Tachfouti N, Belkacemi Y, Raherison C, Bekkali R, Benider A, Nejjari C. Asian Pac J Cancer Prev. 2012;13(4):1547-51. PMID: 22799364
by AROME webmaster, 10 Jan 2013

Fight against cancer around the Mediterranean area: “Many hands make light work!”

January 10th, 2013|

Fight against cancer around the Mediterranean area: “Many hands make light work!” Belkacémi Y, Boussen H, Turkan S, Tsoutsou PG, Geara F, Gligorov J. Crit Rev Oncol Hematol. 2012 Nov 20. doi:pii: S1040-8428(12)00210-7. PMID: 23177098
http://www.ncbi.nlm.nih.gov/pubmed/23177098
by AROME webmaster, 10 Jan 2013

Prevention and management of major side effects of targeted agents in breast cancer

January 5th, 2013|

Posted by AROME webmaster on January 5, 2013
Prevention and management of major side effects of targeted agents in breast cancer. Metzger Filho O, Saini KS, Azim HA Jr, Awada A; on behalf of AROME.Crit Rev Oncol Hematol. …

Update on medical therapies of nasopharyngeal carcinomas

June 16th, 2012|

Posted by AROME webmaster on June 16, 2012

Update on medical therapies of nasopharyngeal carcinomas – Bull Cancer. 2010 Apr;97(4):417-26. French Boussen H, Bouaouina N, Daldoul O, Benna F, Gritli S, Ladgham A.

Optimal sequence of implied modalities in the adjuvant setting

February 17th, 2012|

Posted by AROME webmaster on February 17, 2012
Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider. Tsoutsou PG, Belkacemi Y, Gligorov J, Kuten A, Boussen H, Bese …